VMD: Explanation for business results in quarter 3/2010

Vimedimex Medi-Pharma Joint Stock Company (VIMEDIMEX) (HOSE: VMD) has explained profit before tax in quarter 3/2010 decreased 1.77 billion dongs (19.59%) beside quarter 3/2009 as follows:

• Net revenue increased 16.55% (222.7 billion dongs) and cost of goods sold increased 16.87% (204.91 billion dongs) because revenue from exporting medicine, material, equipments and chemical for tests (Holding 80% of total net revenue) increased 10% and exchange rate of USD also increased (exchange rate at 17,840 VND/USD in September 2009 and at 19,500 VND/USD at September 2010).

• Gross profit increased 13.58% (17.78 billion dongs) but net revenue increased 16.55% and cost of goods sold increased 16.87% because the company could not adjust prices of products supplied to hospitals and other companies (Exchange rate at 19,100 VND/USD in July 2010 and at 19,500 VND/USD at September 2010).

hose

>   KTB: Explanation for business results in quarter 3/2010 (07/12/2010)

>   SEC: Explanation for business results in quarter 3/2010 (07/12/2010)

>   BT6: Explanation for some items in audited statements of 06 months 2010 (07/12/2010)

>   BCI: Explanation for business results in quarter 3/2010 (07/12/2010)

>   TNA: Business result in November 2010 (07/12/2010)

>   SJS: Resolution on selling a part of capital in PVPower Land (07/12/2010)

>   PXI: Setting up a subsidiary (07/12/2010)

>   VHC: Explanation for business result in Q3.2010 (06/12/2010)

>   BT6: Extension of the submission date for Q3/2010 FS (03/12/2010)

>   VST: Information on handing ship over buyer (02/12/2010)